Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	491.73	398.2	214.2	140.83	119.07
Revenue Growth (YoY)	23.49%	85.90%	52.10%	18.27%	16.39%
Cost of Revenue	70.62	53.45	36.12	38.82	33.54
Gross Profit	421.11	344.76	178.08	102.01	85.54
Selling, General & Admin	177.74	133.71	57.09	49.63	44.23
Research & Development	10.87	91.67	18.06	-	-
Operating Expenses	225.99	257.94	76.24	49.63	44.23
Operating Income	195.12	86.81	101.84	52.39	41.3
Interest & Investment Income	16.06	4.68	-	0.28	0.59
Other Non Operating Income (Expenses)	-	-	2.88	-	-
EBT Excluding Unusual Items	211.19	91.49	104.72	52.67	41.89
Gain (Loss) on Sale of Investments	5.08	3.02	-	-	-
Pretax Income	216.26	94.51	104.72	52.67	41.89
Income Tax Expense	52.37	23.1	21.64	13.19	-33.09
Net Income	163.89	71.41	83.08	39.48	74.98
Net Income to Common	163.89	71.41	83.08	39.48	74.98
Net Income Growth	129.50%	-14.05%	110.42%	-47.34%	135.24%
Shares Outstanding (Basic)	118	106	103	103	104
Shares Outstanding (Diluted)	125	114	111	108	106
Shares Change (YoY)	9.84%	2.14%	3.32%	1.46%	0.21%
EPS (Basic)	1.38	0.67	0.80	0.38	0.72
EPS (Diluted)	1.31	0.63	0.75	0.37	0.71
EPS Growth	107.94%	-16.00%	102.70%	-47.89%	136.67%
Free Cash Flow	239.25	-54.92	106.02	59.35	45.02
Free Cash Flow Per Share	1.92	-0.48	0.95	0.55	0.42
Gross Margin	85.64%	86.58%	83.14%	72.44%	71.84%
Operating Margin	39.68%	21.80%	47.54%	37.20%	34.69%
Profit Margin	33.33%	17.93%	38.78%	28.04%	62.97%
Free Cash Flow Margin	48.66%	-13.79%	49.49%	42.14%	37.81%
EBITDA	232.9	119.69	103.08	52.58	41.4
EBITDA Margin	47.36%	30.06%	48.12%	37.33%	34.76%
D&A For EBITDA	37.77	32.88	1.24	0.19	0.09
EBIT	195.12	86.81	101.84	52.39	41.3
EBIT Margin	39.68%	21.80%	47.54%	37.20%	34.69%
Effective Tax Rate	24.22%	24.44%	20.66%	25.04%	-
Revenue as Reported	491.73	398.2	214.2	140.83	119.07
Advertising Expenses	10	9.1	3.3	2.9	2.5

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q